Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study

Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study

Objective: Limited real-world efficacy and safety data exist regarding the use of trastuzumab deruxtecan (T-DXd) in the Chinese population with human epidermal growth factor receptor (HER2)-positive and HER2-low advanced breast cancer (BC). This multicenter, observational, real-world study aimed to...

Full description

Saved in:
Bibliographic Details
Main Authors: Die Sang, Yanfang Su, Yurong Zhang, Yanfeng Guan, Shanmin Fan, Jintao Zhang, Lijun Zheng, Yanling Wang, Ying Guo, Zixuan Lei, Man Li, Peng Yuan
Format: Article
Language:English
Published: SAGE Publishing 2025-02-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359251318853
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items